Showing 23,074 news articles about PEP

Filters Content type: Editors' picks Topic: PEP

Post-exposure prophylaxis involves taking a 28-day course of anti-HIV drugs, after possible exposure to HIV. It may be used by healthcare workers (occupational PEP) or after sex (post-exposure prophylaxis after sexual exposure, PEPSE, also known as non-occupational PEP or nPEP).

The search for a cure

Why some people naturally control HIV even after stopping therapy - and how we can leverage that to treat others

Editor's pick
EurekAlert!
23 March 2026
Neurological & cognitive problems

Long American study explores trends in dementia among people with and without HIV

Editor's pick
CATIE
24 March 2026
Injectable & long-acting PrEP

The Launch of Lenacapavir in Zambia

Editor's pick
AVAC
25 March 2026
Bad science & bogus treatments

HIV/AIDS Denialism Is Back, Courtesy of Joe Rogan

Editor's pick
McGill Office for Science and Society
25 March 2026
Finance & funding

Florida Restores Access to Low-Cost H.I.V. Medications After Uproar

Editor's pick
The New York Times (requires free registration)
26 March 2026
Sexually transmitted infections epidemiology

Increase in drug-resistant Shigella cases among gay and bisexual men

Editor's pick
UK Health Security Agency
26 March 2026
Activism & civil society

In This Moment of Crisis, Peter Staley Urges the HIV Community to Act Together

Editor's pick
TheBody
27 March 2026
Cardiovascular disease

Even Low HIV Load Can Double Heart Disease Risk

Editor's pick
Medscape (requires free registration)
30 March 2026
HIV & criminal law

'Take the Test, Risk Arrest': Why Some HIV-Positive Americans Are Still Forced to Register as Sex Offenders

Editor's pick
Uncloseted Media
30 March 2026
Opportunistic infections

Herpes Zoster Incidence Remains Elevated for People With HIV, and at Younger Ages

Editor's pick
TheBodyPro
30 March 2026
Injectable & long-acting PrEP

Solving the PrEP Access Problem, One Subscription at a Time

Editor's pick
TheBodyPro
30 March 2026
Activism & civil society

AIDSWatch 2026: Highlights From the HIV Advocacy Event on the Hill

Editor's pick
POZ
30 March 2026
Global health initiatives

Lesotho organisations push back against US health deal

Editor's pick
GroundUp News
31 March 2026
People & personal stories

Demetre Daskalakis gets back to his roots

Editor's pick
POZ
31 March 2026
HIV in the arts & media

Writes & Wrongs: Graphic Novel “Bitter Pill” Reimagines AIDS Icon Randy Shilts

Editor's pick
POZ
31 March 2026
Employment

U.S. Military: Still Fighting to Serve

Editor's pick
POZ
31 March 2026
Injectable & long-acting PrEP

Gilead refuses to sell groundbreaking HIV prevention drug to MSF

Editor's pick
Médecins Sans Frontières
31 March 2026
Global health initiatives

Is Trump killing the heralded U.S. effort to help the world battle HIV?

Editor's pick
Science
31 March 2026
Coronavirus

Does HIV Status Affect Long COVID Manifestations?

Editor's pick
Medscape (requires free registration)
1 April 2026
Human rights

Senegal: President signs off on LGBTQ law doubling maximum jail term for same-sex relations

Editor's pick
Deutsche Welle
1 April 2026
Chemsex & recreational drug use

Antidepressant Reduces Meth Addiction in Trial

Editor's pick
MedPage Today
1 April 2026
People & personal stories

Farewell, Stephen Lewis, the man who shamed the world into seeing Africa's Aids catastrophe

Editor's pick
Daily Maverick
1 April 2026
Finance & funding

With US Aid Slashed, Nigerian HIV Volunteers Went Door‑to‑door to Keep Patients Alive

Editor's pick
Medscape (requires free registration)
1 April 2026
New & experimental HIV treatments

Gilead cancels midstage HIV trial as FDA’s clinical hold remains intact

Editor's pick
FierceBiotech
2 April 2026